Singapore’s medical device landscape continues to evolve with the integration of artificial intelligence (AI) in routine clinical practice. The increasing focus on advanced imaging and diagnostic solutions is driving efforts to support clinicians with tools to enhance disease detection and decision-making. Such trend aligns with Singapore’s focus on building a future-ready healthcare system that can meet rising demand and complexity, says GlobalData, a leading intelligence and productivity platform.

Intelligent Scopes Corp (ISC), a US-based medical technology company, has recently received regulatory approval from Singapore’s Health Sciences Authority (HSA) for its AI-powered software tool CystoSmart, which is designed to support bladder cancer detection. The approval marks a significant step toward strengthening Singapore’s diagnostic capabilities.

Anindita Ghosh, Medical Devices Analyst at GlobalData, comments: “AI-based software offers several advantages in clinical practice by supporting faster and more consistent interpretation of medical images. By assisting clinicians in identifying subtle patterns that may be difficult to detect through conventional methods alone, such tools can help reduce variability in diagnosis, improve efficiency of workflow and support clinical decision making while continuing to rely on clinician oversight for final assessment.”

Designed to analyze cystoscopy images, CystoSmart helps clinicians to detect and characterize lesions, helping to reduce variability in interpretation and supporting timely clinical assessment. Its approval in Singapore reflects continued adoption of clinically focused AI tools in routine practice. By supporting image interpretation during cystoscopy, the technology is expected to enhance diagnostic confidence while maintaining clinical oversight.

Ghosh concludes: “Singapore’s digital health landscape is increasingly defined by structured oversight and real-world implementation. This enables digital health solutions to be used more reliably across Singapore’s healthcare system.”